Plasmablastic lymphomas may occur as post-transplant lymphoproliferative disorders

被引:48
作者
Borenstein, J. [1 ]
Pezzella, F. [1 ]
Gatter, K. C. [1 ]
机构
[1] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Lab Sci, Oxford OX3 9DU, England
关键词
plasmablastic; lymphoma; post-transplantation;
D O I
10.1111/j.1365-2559.2007.02870.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Aims: To describe four cases of plasmablastic lymphoma arising in the unusual setting of a post-transplantation lymphoproliferative disorder (PTLD). Methods and results: Four cases were encountered over 2 years in human immunodeficiency virus (HIV)-negative patients following renal, heart or bone marrow transplantation. The cases were routinely processed and immunohistochemistry was performed. The cases showed blastic non-Hodgkin's lymphoma morphology and plasma cell-like immunophenotypic features: minimal or absent expression of leucocyte common antigen and CD20, variable CD79a and VS38 positivity. Monoclonal light chain restriction was also detected. Conclusions: The emphasis of this paper is to document further the occurrence of plasmablastic lymphomas in HIV- individuals and to expand the spectrum of PTLD.
引用
收藏
页码:774 / 777
页数:4
相关论文
共 14 条
[1]  
[Anonymous], 2001, Neoplastic hematopathology
[2]  
[Anonymous], 2001, PATHOLOGY GENETICS T
[3]   Post-transplant lymphoproliferative disorders: molecular basis of disease histogenesis and pathogenesis [J].
Capello, D ;
Rossi, D ;
Gaidano, G .
HEMATOLOGICAL ONCOLOGY, 2005, 23 (02) :61-67
[4]   Plasmablastic lymphoma in HIV+ patients: an expanding spectrum [J].
Chetty, R ;
Hlatswayo, N ;
Muc, R ;
Sabaratnam, R ;
Gatter, K .
HISTOPATHOLOGY, 2003, 42 (06) :605-609
[5]   Plasmablastic lymphomas of the oral cavity: A new entity associated with the human immunodeficiency virus infection [J].
Delecluse, HJ ;
Anagnostopoulos, I ;
Dallenbach, F ;
Hummel, M ;
Marafioti, T ;
Schneider, U ;
Huhn, D ;
SchmidtWesthausen, A ;
Reichart, PA ;
Gross, U ;
Stein, H .
BLOOD, 1997, 89 (04) :1413-1420
[6]  
Folk Gretchen S, 2006, Ann Diagn Pathol, V10, P8, DOI 10.1016/j.anndiagpath.2005.07.009
[7]  
FRIZZERA G, 2001, NEOPLASTIC HEMATHOLO, P579
[8]  
Lin F, 2004, ARCH PATHOL LAB MED, V128, P581
[9]   Expression of PAX5 in CD20-positive multiple myeloma assessed by immunohistochemistry and oligonucleotide microarray [J].
Lin, P ;
Mahdavy, M ;
Zhan, FH ;
Zhang, HZ ;
Katz, RL ;
Shaughnessy, JD .
MODERN PATHOLOGY, 2004, 17 (10) :1217-1222
[10]  
Lin Y, 2001, ARCH PATHOL LAB MED, V125, P282